ADIL
Price
$0.34
Change
+$0.01 (+3.03%)
Updated
Sep 26 closing price
Capitalization
7.51M
VYNE
Price
$0.33
Change
+$0.01 (+3.12%)
Updated
Sep 26 closing price
Capitalization
8.45M
Interact to see
Advertisement

ADIL vs VYNE

Header iconADIL vs VYNE Comparison
Open Charts ADIL vs VYNEBanner chart's image
Adial Pharmaceuticals
Price$0.34
Change+$0.01 (+3.03%)
Volume$604.15K
Capitalization7.51M
VYNE Therapeutics
Price$0.33
Change+$0.01 (+3.12%)
Volume$1.46M
Capitalization8.45M
ADIL vs VYNE Comparison Chart in %
Loading...
ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADIL vs. VYNE commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADIL is a Buy and VYNE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (ADIL: $0.34 vs. VYNE: $0.33)
Brand notoriety: ADIL and VYNE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADIL: 39% vs. VYNE: 52%
Market capitalization -- ADIL: $7.51M vs. VYNE: $8.45M
ADIL [@Biotechnology] is valued at $7.51M. VYNE’s [@Biotechnology] market capitalization is $8.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADIL’s FA Score shows that 1 FA rating(s) are green whileVYNE’s FA Score has 2 green FA rating(s).

  • ADIL’s FA Score: 1 green, 4 red.
  • VYNE’s FA Score: 2 green, 3 red.
According to our system of comparison, both ADIL and VYNE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADIL’s TA Score shows that 5 TA indicator(s) are bullish while VYNE’s TA Score has 4 bullish TA indicator(s).

  • ADIL’s TA Score: 5 bullish, 3 bearish.
  • VYNE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ADIL is a better buy in the short-term than VYNE.

Price Growth

ADIL (@Biotechnology) experienced а -1.69% price change this week, while VYNE (@Biotechnology) price change was +9.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYNE($8.45M) has a higher market cap than ADIL($7.51M). ADIL YTD gains are higher at: -65.931 vs. VYNE (-90.096). ADIL has higher annual earnings (EBITDA): -8.3M vs. VYNE (-42.58M). VYNE has more cash in the bank: 39.6M vs. ADIL (5.92M). VYNE has less debt than ADIL: VYNE (25K) vs ADIL (194K). VYNE has higher revenues than ADIL: VYNE (476K) vs ADIL (0).
ADILVYNEADIL / VYNE
Capitalization7.51M8.45M89%
EBITDA-8.3M-42.58M19%
Gain YTD-65.931-90.09673%
P/E RatioN/A0.71-
Revenue0476K-
Total Cash5.92M39.6M15%
Total Debt194K25K776%
FUNDAMENTALS RATINGS
ADIL vs VYNE: Fundamental Ratings
ADIL
VYNE
OUTLOOK RATING
1..100
1074
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
17
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
6565
P/E GROWTH RATING
1..100
491
SEASONALITY SCORE
1..100
n/a41

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADIL's Valuation (17) in the Pharmaceuticals Major industry is in the same range as VYNE (17). This means that ADIL’s stock grew similarly to VYNE’s over the last 12 months.

ADIL's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as VYNE (100). This means that ADIL’s stock grew similarly to VYNE’s over the last 12 months.

VYNE's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as ADIL (99). This means that VYNE’s stock grew similarly to ADIL’s over the last 12 months.

VYNE's Price Growth Rating (65) in the Pharmaceuticals Major industry is in the same range as ADIL (65). This means that VYNE’s stock grew similarly to ADIL’s over the last 12 months.

VYNE's P/E Growth Rating (1) in the Pharmaceuticals Major industry is somewhat better than the same rating for ADIL (49). This means that VYNE’s stock grew somewhat faster than ADIL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADILVYNE
RSI
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 7 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALXO1.870.08
+4.47%
ALX Oncology Holdings
CPRX19.520.39
+2.04%
Catalyst Pharmaceuticals
MYNZ1.55N/A
N/A
Mainz Biomed N.V.
CBNK32.10-0.43
-1.32%
Capital Bancorp
XPO126.05-3.10
-2.40%
XPO

ADIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADIL has been loosely correlated with VANI. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ADIL jumps, then VANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADIL
1D Price
Change %
ADIL100%
+2.81%
VANI - ADIL
37%
Loosely correlated
N/A
CLYM - ADIL
34%
Loosely correlated
+1.43%
GDTC - ADIL
30%
Poorly correlated
+1.02%
VYNE - ADIL
30%
Poorly correlated
+5.00%
VTVT - ADIL
28%
Poorly correlated
-2.10%
More

VYNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYNE has been loosely correlated with NEVPF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VYNE jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYNE
1D Price
Change %
VYNE100%
+5.00%
NEVPF - VYNE
52%
Loosely correlated
N/A
SYRE - VYNE
36%
Loosely correlated
+4.04%
ABVX - VYNE
34%
Loosely correlated
+1.02%
SPRB - VYNE
34%
Loosely correlated
N/A
EYPT - VYNE
33%
Loosely correlated
+5.38%
More